Muc1 have been attracted much attention as a cancer immunotherapy target as it is frequently overexpressed in many types of cancers, including colon, lung, pancreas, breast, ovarian, prostate, kidney, stomach and head and neck cancers [14–16]. Here, MUC1 is linked to cancer.